Procalcitonin Guided Antibiotic Therapy in Lower Respiratory Infections
Author Information
Author(s): Philipp Schuetz, Mirjam Christ-Crain, Marcel Wolbers, Ursula Schild, Robert Thomann, Claudine Falconnier, Isabelle Widmer, Stefanie Neidert, Claudine A Blum, Ronald Schönenberger, Christoph Henzen, Thomas Bregenzer, Claus Hoess, Martin Krause, Heiner C Bucher, Wernher Zimmerli, Beat Müller
Primary Institution: University Hospital Basel
Hypothesis
Procalcitonin-guidance is non-inferior to management with enforced guidelines but is associated with reduced total antibiotic use and length of hospital stay.
Conclusion
The study aims to determine if procalcitonin-guided therapy can safely reduce antibiotic use and hospitalization costs without compromising patient outcomes.
Supporting Evidence
- Lower respiratory tract infections account for a significant burden of morbidity and mortality.
- 75% of antibiotics are prescribed for viral infections due to difficulty in diagnosis.
- Procalcitonin levels correlate with the likelihood of bacterial infection.
Takeaway
This study is trying to find out if using a special test can help doctors give fewer antibiotics to patients with lung infections while still keeping them safe.
Methodology
A prospective randomized controlled non-inferiority trial comparing procalcitonin-guided therapy to guidelines-enforced management.
Potential Biases
Potential biases include the Hawthorne effect and spill-over effects from the intervention group to the control group.
Limitations
Previous trials had limitations in external validity and did not adequately address the length of hospital stay.
Participant Demographics
Patients must be over 18 years old with lower respiratory tract infections lasting less than 28 days.
Statistical Information
Confidence Interval
90%
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website